GO:0090677 reversible differentiation: Phenotypic Switching, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090677 reversible differentiation describes a phenotypic switching process in which a cell reversibly differentiates and dedifferentiates from one cell type into another [1, 3, 4].
• Reversible differentiation is experimentally observed in pluripotent cells, cardiac fibroblasts, myofibroblasts, multipotent stromal cells, and leukemia cell lines [2, 3, 4, 6, 8].
• The transition between reversible and irreversible states often involves heterochromatin remodeling, as shown at the DM1 locus where differentiation shifts from a reversible to an irreversible heterochromatin state.
• Signaling pathways including NF-kB and WNT, as well as osmolar modulation, can drive reversible cell cycle exit and differentiation in human pluripotent cells.
• Reversible commitment to differentiation has been demonstrated in single-cell-derived colonies of human multipotent stromal cells, indicating that differentiation potential can be retained and reversed.
• Reversibility of differentiation is relevant to aging, fibrosis, and cancer biology, where cells may dedifferentiate or re-enter the cell cycle [3, 7, 8].
Description
Reversible differentiation (GO:0090677) is a biological process in which a cell undergoes a phenotypic switch, differentiating from one cell type into another and then dedifferentiating back to its original state or to an intermediate state [1, 3, 4]. This process is distinct from terminal differentiation because it allows cells to retain or regain plasticity, enabling them to respond to environmental or experimental cues [4, 6]. The concept has been documented in multiple cell types, including pluripotent stem cells, cardiac fibroblasts, myofibroblasts, and multipotent stromal cells [2, 3, 4, 6, 8]. Understanding reversible differentiation is important for developmental biology, regenerative medicine, and disease modeling, as it may explain how cells switch identities during tissue repair, fibrosis, or tumor progression [3, 7, 8]. Experimental evidence shows that reversible differentiation can be modulated by external factors such as osmolarity, signaling pathways like NF-kB and WNT, and chromatin state [1, 5]. This article provides a research-grade overview of GO:0090677, covering its definition, mechanisms, key genes, disease relevance, and methods for study.
reversible differentiation At A Glance
| GO ID | GO:0090677 |
|---|---|
| GO term | reversible differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Phenotypic switching with reversible differentiation and dedifferentiation between cell types |
| Related processes | Cell fate plasticity, dedifferentiation, transdifferentiation, cell cycle exit |
| Experimental evidence | Observed in pluripotent cells, cardiac fibroblasts, myofibroblasts, multipotent stromal cells, and THP-1 cells [2, 3, 4, 6, 8] |
| Key regulators | NF-kB, WNT signaling, osmolarity, heterochromatin state [1, 5] |
| Disease relevance | Fibrosis, aging, cancer, and developmental disorders [3, 7, 8] |
What Is GO:0090677?
According to the Gene Ontology, reversible differentiation (GO:0090677) is a phenotypic switching process where a cell reversibly differentiates and dedifferentiates from one cell type into another. In other words, the cell can change its identity and then revert, rather than committing irreversibly to a new state. This definition is supported by experimental observations in pluripotent cells, fibroblasts, and stromal cells, where differentiation can be reversed under specific conditions [1, 3, 4, 6].
Why Is reversible differentiation Important in Cell Biology?
Reversible differentiation is important because it challenges the traditional view that differentiation is a one-way process. Cells that can reversibly differentiate may contribute to tissue regeneration, but they may also drive pathological states such as fibrosis or tumor heterogeneity [3, 7, 8]. Understanding the molecular switches that control reversibility could enable new therapeutic strategies for regenerative medicine and cancer [1, 5].
• Provides a mechanism for cell fate plasticity in development and tissue repair [4, 6].
• Explains how fibroblasts and myofibroblasts can switch phenotypes in fibrosis [3, 8].
• Relevant to aging research, as reversibility of differentiation may decline with age.
• Implicated in cancer, where dedifferentiation can contribute to tumor progression.
• Key for optimizing cell-based assays, such as THP-1 differentiation for immune studies.
• Involves epigenetic regulation, including heterochromatin remodeling.
• Can be modulated by signaling pathways like NF-kB and WNT.
• Enables single-cell-derived colonies to retain multipotency.
• Important for understanding osmolarity effects on pluripotent cell differentiation.
• Offers targets for CRISPR-based screens to identify regulators of reversibility [1, 3, 5].
What Happens During reversible differentiation?
Initiation of differentiation
In simple terms: A cell receives a signal to change into a different cell type.
Reversible differentiation begins when a cell responds to external or internal cues, such as changes in osmolarity or signaling pathway activation, leading to a phenotypic switch. For example, human pluripotent cells can exit the cell cycle and differentiate in response to osmolar modulation via NF-kB and WNT signaling. Similarly, THP-1 cells can be differentiated into macrophage-like cells under optimized conditions.
Maintenance of the differentiated state
In simple terms: The cell maintains its new identity for a period of time.
Once differentiated, the cell may express lineage-specific markers and acquire new functions. In cardiac fibroblasts, differentiation into myofibroblasts can be reversible or irreversible depending on the context. In multipotent stromal cells, commitment to differentiation can be maintained in single-cell-derived colonies.
Dedifferentiation and reversal
In simple terms: The cell can revert to its original state or to a less specialized state.
Reversible differentiation is characterized by the ability to dedifferentiate. For instance, myofibroblast differentiation in adipose-derived mesenchymal stem cells can be reversibly modulated. Pluripotent cell differentiation can also be reversed under specific conditions, as shown by reversible programming of pluripotent cell differentiation.
Epigenetic and chromatin changes
In simple terms: The cell's DNA packaging changes to allow or block reversal.
The transition between reversible and irreversible differentiation often involves changes in chromatin state. At the DM1 locus, differentiation shifts from a reversible to an irreversible heterochromatin state. This suggests that heterochromatin formation can lock cells into a differentiated state, while a more open chromatin configuration permits reversibility.
Signaling pathways controlling reversibility
In simple terms: Specific molecular signals decide whether the cell can go back.
NF-kB and WNT signaling are involved in osmolar modulation-driven reversible cell cycle exit and differentiation in human pluripotent cells. These pathways may serve as switches that determine whether differentiation is reversible or terminal.
Key Genes Involved in GO:0090677 reversible differentiation
The following genes and proteins have been implicated in reversible differentiation or related phenotypic switching processes based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFKB1 | NF-kB signaling component involved in osmolar modulation-driven differentiation | Studied in human pluripotent cell differentiation |
| WNT3A | WNT signaling ligand that can influence differentiation reversibility | Implicated in reversible cell cycle exit |
| DM1 | Locus where heterochromatin state shifts from reversible to irreversible during differentiation | Model for epigenetic regulation of reversibility |
| THP-1 | Cell line used to study optimized differentiation for weak stimuli | Model for macrophage differentiation |
| CDH1 | Epithelial marker often used to assess differentiation state | Potential marker in reversible differentiation studies |
| ACTA2 | Myofibroblast marker, indicates differentiated state | Used to monitor reversible myofibroblast differentiation |
| VIM | Mesenchymal marker, indicates dedifferentiated state | Used in cardiac fibroblast studies |
| POU5F1 | Pluripotency marker, indicates undifferentiated state | Studied in reversible programming of pluripotent cells |
| NANOG | Pluripotency transcription factor | Relevant to reversible differentiation in pluripotent cells |
| SOX2 | Pluripotency transcription factor | Involved in maintaining reversible states |
| KLF4 | Pluripotency factor, can influence differentiation | Studied in reprogramming and reversibility |
| MYC | Proliferation and differentiation regulator | Potential target in reversible differentiation |
| CDKN1A | Cell cycle inhibitor, involved in cell cycle exit | Studied in osmolar modulation-driven differentiation |
| CDKN1B | Cell cycle inhibitor, involved in quiescence | Relevant to reversible cell cycle exit |
| COL1A1 | Extracellular matrix component, marker of fibrosis | Used in myofibroblast differentiation studies |
| FN1 | Fibronectin, marker of mesenchymal state | Used in cardiac fibroblast differentiation |
| PPARG | Adipogenic transcription factor | Studied in adipose-derived stem cell differentiation |
| RUNX2 | Osteogenic transcription factor | Studied in multipotent stromal cell differentiation |
How Is reversible differentiation Regulated?
Reversible differentiation is regulated by a combination of signaling pathways, epigenetic modifiers, and environmental factors. NF-kB and WNT signaling have been shown to mediate osmolar modulation-driven reversible cell cycle exit and differentiation in human pluripotent cells. Heterochromatin formation can shift differentiation from reversible to irreversible, as observed at the DM1 locus. Additionally, the reversibility of differentiation may decline with aging, as proposed in the context of irreversible aging. These regulatory mechanisms provide potential targets for experimental manipulation.
reversible differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACTA2 | Fibrosis | Knockout or overexpression in cardiac fibroblasts [3, 8] |
| NFKB1 | Inflammation and differentiation | Point mutation in pluripotent cells |
| DM1 | Myotonic dystrophy type 1 | Knock-in of expanded repeats in cell models |
| PPARG | Adipogenesis and metabolic disorders | Overexpression in adipose-derived stem cells |
| RUNX2 | Osteogenesis and bone disorders | Knockout in multipotent stromal cells |
Fibrosis and tissue remodeling
Reversible differentiation of fibroblasts and myofibroblasts is central to fibrosis. Cardiac fibroblasts can undergo reversible or irreversible differentiation, and myofibroblast differentiation in adipose-derived mesenchymal stem cells can be reversibly modulated [3, 8]. Dysregulation of this reversibility may lead to excessive scar formation or impaired tissue repair [3, 8].
Cancer and dedifferentiation
Reversibility of differentiation is relevant to cancer, where dedifferentiation can contribute to tumor heterogeneity and progression. The concept of reversibility of irreversible aging suggests that cellular states once thought permanent may be reversed, with implications for cancer therapy. Heterochromatin changes at loci like DM1 may also play a role in cancer-associated epigenetic reprogramming.
Aging and regenerative decline
Aging is associated with a loss of reversible differentiation capacity, as discussed in the context of reversibility of irreversible aging. This decline may impair tissue regeneration and contribute to age-related diseases.
Immune cell differentiation
Optimized differentiation of THP-1 cells is required for detecting responses to weak stimuli, highlighting the importance of reversible differentiation in immune cell models. This has implications for studying inflammation and immune-related diseases.
From reversible differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is NFKB1 required for reversible differentiation? | NFKB1 knockout in human pluripotent cells |
| Does a point mutation in WNT3A affect reversibility? | WNT3A point-mutation knock-in in pluripotent cells |
| Can heterochromatin state be reversed at DM1 locus? | DM1 knock-in with tagged heterochromatin markers |
| What is the role of ACTA2 in myofibroblast reversibility? | ACTA2 overexpression in adipose-derived stem cells |
| Does PPARG overexpression enhance reversible adipogenesis? | PPARG overexpression in mesenchymal stem cells |
| Is RUNX2 required for osteogenic reversibility? | RUNX2 knockout in multipotent stromal cells |
How to Study the reversible differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Tracking differentiation and dedifferentiation [4, 5] |
| ATAC-seq | Chromatin accessibility | Assessing heterochromatin state |
| ChIP-seq | Histone modifications and transcription factor binding | Studying epigenetic regulation |
| Live-cell imaging | Dynamic changes in cell phenotype | Visualizing reversible differentiation |
| Single-cell RNA-seq | Heterogeneity in differentiation states | Identifying reversible subpopulations |
| Western blot | Protein expression levels | Validating markers like ACTA2 and VIM [3, 8] |
| Flow cytometry | Surface marker expression | Sorting differentiated and undifferentiated cells |
| CRISPR screening | Gene function on a large scale | Identifying regulators of reversibility [1, 5] |
Transcriptomic profiling
RNA sequencing can be used to track changes in gene expression during reversible differentiation. For example, pluripotency markers such as POU5F1 and NANOG can be monitored to assess the undifferentiated state, while lineage markers indicate differentiation [4, 5].
Epigenetic analysis
ATAC-seq or ChIP-seq for heterochromatin marks can reveal whether differentiation is reversible or irreversible. At the DM1 locus, heterochromatin state shifts from reversible to irreversible, which can be detected by these methods.
Imaging and lineage tracing
Live-cell imaging with fluorescent reporters for lineage-specific markers can visualize reversible differentiation in real time. This approach has been used to study cardiac fibroblast differentiation.
Single-cell analysis
Single-cell RNA sequencing can identify subpopulations of cells that retain reversibility potential, as demonstrated in single-cell-derived colonies of multipotent stromal cells.
How CRISPR Can Be Used to Study GO:0090677 reversible differentiation
Knockout
CRISPR knockout can be used to test whether a candidate gene is required for reversible differentiation. For example, knocking out NFKB1 in human pluripotent cells can reveal its role in osmolar modulation-driven differentiation.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that may affect reversibility. For instance, mutating key residues in WNT3A could alter its ability to promote reversible cell cycle exit.
Knock-in
Knock-in of reporter genes or disease-associated repeats can help track reversible differentiation. A DM1 repeat knock-in can be used to study the shift from reversible to irreversible heterochromatin.
Overexpression
Overexpression of transcription factors like PPARG or RUNX2 can drive differentiation and test whether the process remains reversible [6, 8].
How EDITGENE Supports reversible differentiation Research
Researchers studying reversible differentiation-related genes often need to determine whether a candidate gene is causally involved in the phenotypic switch or is merely a bystander. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides these services to accelerate discovery in this field.
Contact EDITGENE today to design your custom CRISPR model for reversible differentiation research.
Frequently Asked Questions About reversible differentiation
What is reversible differentiation?
Reversible differentiation (GO:0090677) is a phenotypic switching process where a cell reversibly differentiates and dedifferentiates from one cell type into another [1, 3, 4].
What genes are involved in reversible differentiation?
Genes such as NFKB1, WNT3A, ACTA2, PPARG, and RUNX2 have been implicated in reversible differentiation or related processes [5, 6, 8].
How is reversible differentiation regulated?
It is regulated by signaling pathways like NF-kB and WNT, as well as epigenetic changes such as heterochromatin formation [1, 5].
What diseases are associated with reversible differentiation?
Fibrosis, cancer, aging, and immune disorders may involve dysregulated reversible differentiation [2, 3, 7, 8].
What methods are used to study reversible differentiation?
RNA-seq, ATAC-seq, ChIP-seq, live-cell imaging, and single-cell RNA-seq are commonly used [1, 3, 4, 6].
Can CRISPR be used to study reversible differentiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test gene function in reversible differentiation [1, 5, 6, 8].
What is the difference between reversible and irreversible differentiation?
Reversible differentiation allows cells to dedifferentiate, while irreversible differentiation locks cells into a terminal state, often via heterochromatin [1, 3].
Which cell types exhibit reversible differentiation?
Pluripotent cells, cardiac fibroblasts, myofibroblasts, multipotent stromal cells, and THP-1 cells can exhibit reversible differentiation [2, 3, 4, 6, 8].
How does aging affect reversible differentiation?
Aging may reduce the reversibility of differentiation, contributing to regenerative decline.
What is the role of heterochromatin in reversible differentiation?
Heterochromatin formation can shift differentiation from reversible to irreversible, as shown at the DM1 locus.
Conclusion
Reversible differentiation (GO:0090677) is a fundamental biological process that allows cells to switch identities and revert, with implications for development, regeneration, and disease. Key regulators include NF-kB, WNT signaling, and epigenetic modifiers such as heterochromatin [1, 5]. Experimental models ranging from pluripotent cells to fibroblasts and stromal cells have provided insights into the mechanisms and reversibility of differentiation [2, 3, 4, 6, 8]. Future research using CRISPR-based tools will further elucidate the genetic and epigenetic determinants of reversibility.
References
- 1. Handal T et al.. 2024. Differentiation shifts from a reversible to an irreversible heterochromatin state at the DM1 locus.. Nat Commun 15(1):3270 PMID: 38627364
- 2. Park EK et al.. 2007. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.. Inflamm Res 56(1):45-50 PMID: 17334670
- 3. Driesen RB et al.. 2014. Reversible and irreversible differentiation of cardiac fibroblasts.. Cardiovasc Res 101(3):411-22 PMID: 24368833
- 4. Lake J et al.. 2000. Reversible programming of pluripotent cell differentiation.. J Cell Sci 113 ( Pt 3):555-66 PMID: 10639341
- 5. Chui JS et al.. 2024. Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF-κВ and WNT Signaling.. Adv Sci (Weinh) 11(7):e2307554 PMID: 38037844
- 6. Ylöstalo J et al.. 2008. Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies.. Exp Hematol 36(10):1390-402 PMID: 18619725
- 7. Galkin F et al.. 2019. Reversibility of irreversible aging.. Ageing Res Rev 49:104-114 PMID: 30513346
- 8. Desai VD et al.. 2014. Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells.. PLoS One 9(1):e86865 PMID: 24466271
